292 related articles for article (PubMed ID: 28838406)
1. Clinical significance of preoperative serum albumin level for prognosis in surgically resected patients with non-small cell lung cancer: Comparative study of normal lung, emphysema, and pulmonary fibrosis.
Miura K; Hamanaka K; Koizumi T; Kitaguchi Y; Terada Y; Nakamura D; Kumeda H; Agatsuma H; Hyogotani A; Kawakami S; Yoshizawa A; Asaka S; Ito KI
Lung Cancer; 2017 Sep; 111():88-95. PubMed ID: 28838406
[TBL] [Abstract][Full Text] [Related]
2. Impact of combined pulmonary fibrosis and emphysema on surgical complications and long-term survival in patients undergoing surgery for non-small-cell lung cancer.
Hata A; Sekine Y; Kota O; Koh E; Yoshino I
Int J Chron Obstruct Pulmon Dis; 2016; 11():1261-8. PubMed ID: 27354784
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of combined pulmonary fibrosis and emphysema in patients with resected non-small-cell lung cancer: a retrospective cohort study.
Kumagai S; Marumo S; Yamanashi K; Tokuno J; Ueda Y; Shoji T; Nishimura T; Huang CL; Fukui M
Eur J Cardiothorac Surg; 2014 Dec; 46(6):e113-9. PubMed ID: 25345566
[TBL] [Abstract][Full Text] [Related]
4. The Preoperative Composite Physiologic Index May Predict Mortality in Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema.
Ueno F; Kitaguchi Y; Shiina T; Asaka S; Miura K; Yasuo M; Wada Y; Yoshizawa A; Hanaoka M
Respiration; 2017; 94(2):198-206. PubMed ID: 28637046
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of combined pulmonary fibrosis and emphysema in patients with clinical stage IA non-small cell lung cancer.
Takenaka T; Furuya K; Yamazaki K; Miura N; Tsutsui K; Takeo S
Surg Today; 2018 Feb; 48(2):229-235. PubMed ID: 28821979
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of preoperative plasma D-dimer level in patients with surgically resected clinical stage I non-small cell lung cancer: a retrospective cohort study.
Kaseda K; Asakura K; Kazama A; Ozawa Y
J Cardiothorac Surg; 2017 Nov; 12(1):102. PubMed ID: 29183325
[TBL] [Abstract][Full Text] [Related]
7. The Prognosis of Small Cell Lung Cancer in Patients with Pulmonary Fibrosis.
Matsumoto Y; Ohara S; Furukawa R; Usui K
Anticancer Res; 2017 Oct; 37(10):5791-5795. PubMed ID: 28982903
[TBL] [Abstract][Full Text] [Related]
8. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients With Stage I Non-Small Cell Lung Cancer Undergoing Complete Resection.
Xia H; Sun Z; Deng L; Zhu D; Wang D
Cancer Invest; 2016 Sep; 34(8):378-84. PubMed ID: 27558529
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of postoperative decrease in serum albumin on surgically resected early-stage non-small cell lung carcinoma: A multicenter retrospective study.
Kinoshita F; Tagawa T; Yamashita T; Takenaka T; Matsubara T; Toyokawa G; Takada K; Oba T; Osoegawa A; Yamazaki K; Takenoyama M; Shimokawa M; Nakashima N; Mori M
PLoS One; 2021; 16(9):e0256894. PubMed ID: 34473762
[TBL] [Abstract][Full Text] [Related]
11. Surgical Outcomes of Lung Cancer Patients with Combined Pulmonary Fibrosis and Emphysema and Those with Idiopathic Pulmonary Fibrosis without Emphysema.
Sato S; Koike T; Hashimoto T; Ishikawa H; Okada A; Watanabe T; Tsuchida M
Ann Thorac Cardiovasc Surg; 2016 Aug; 22(4):216-23. PubMed ID: 27052999
[TBL] [Abstract][Full Text] [Related]
12. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of combination of preoperative platelet count and mean platelet volume in patients with resectable non-small cell lung cancer.
Gao L; Zhang H; Zhang B; Zhang L; Wang C
Oncotarget; 2017 Feb; 8(9):15632-15641. PubMed ID: 28152504
[TBL] [Abstract][Full Text] [Related]
14. Quantitative severity of pulmonary emphysema as a prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.
Lee SJ; Yoo JW; Ju S; Cho YJ; Kim JD; Kim SH; Jang IS; Jeong BK; Lee GW; Jeong YY; Kim HC; Bae K; Jeon KN; Lee JD
Thorac Cancer; 2019 Mar; 10(3):421-427. PubMed ID: 30507005
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].
Shen L; Li ZM; Lu S
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):442-6. PubMed ID: 21875485
[TBL] [Abstract][Full Text] [Related]
16. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes.
Lee DS; Park KR; Kim SJ; Chung MJ; Lee YH; Chang JH; Kang JH; Hong SH; Kim MS; Kim YS
Tumour Biol; 2016 Jan; 37(1):619-25. PubMed ID: 26240025
[TBL] [Abstract][Full Text] [Related]
17. The impact of emphysema on surgical outcomes of early-stage lung cancer: a retrospective study.
Sato S; Nakamura M; Shimizu Y; Goto T; Koike T; Ishikawa H; Tsuchida M
BMC Pulm Med; 2019 Apr; 19(1):73. PubMed ID: 30947705
[TBL] [Abstract][Full Text] [Related]
18. The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer.
Tomita M; Ayabe T; Nakamura K
Interact Cardiovasc Thorac Surg; 2018 Feb; 26(2):288-292. PubMed ID: 29049691
[TBL] [Abstract][Full Text] [Related]
19. Impact of preoperative 18F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer.
Tönnies S; Tönnies M; Kollmeier J; Bauer TT; Förster GJ; Kaiser D; Wernecke KD; Pfannschmidt J
Lung Cancer; 2016 Mar; 93():28-34. PubMed ID: 26898611
[TBL] [Abstract][Full Text] [Related]
20. Similar radiopathological features, but different postoperative recurrence rates, between Stage I lung cancers arising in emphysematous lungs and those arising in nonemphysematous lungs.
Ueda K; Murakami J; Sano F; Hayashi M; Suga K; Hamano K
Eur J Cardiothorac Surg; 2015 May; 47(5):905-11. PubMed ID: 25123673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
